Skip to main content

Advertisement

Log in

Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The aim of this study was to assess the relationship between urinary Smad1 and glomerular hyperfiltration (GHF) in type 2 diabetes mellitus (T2DM), and to explore the factors related to the urinary Smad1 in T2DM. The reference value of the estimated glomerular filtration rate (eGFR) was determined in 248 healthy individuals. 30 patients with GHF, 58 patients with norm-GFR T2DM, and 24 healthy patients who served as controls were recruited. Urinary Smad1, fasting plasma glucose (FPG), fasting serum C-Peptide (C-P), hemoglobin A1C (HbA1c), cystatin C, and other chemistry laboratory parameters of T2DM participants and controls were measured. Patients with GHF had higher levels of urinary Smad1 than the control group, and those with norm-GFR. For T2DM patients with body mass index, age, and gender adjustments, urinary Smad1 was positively correlated with FPG, HbA1C, and eGFR, but negatively correlated with fasting serum C-P. Multivariate linear regression analysis demonstrated that eGFR, HbA1C, and fasting serum C-P were independently associated with urinary Smad1. High levels of urinary Smad1 were found in GHF patients with T2DM, which may be another potential mechanism of GHF in relation to diabetic nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M. Krolewski, P.W. Eggers, J.H. Warram, Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 50, 2041–2046 (1996)

    Article  PubMed  CAS  Google Scholar 

  2. M. Bojestig, H.J. Arnqvist, G. Hermansson et al., Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N. Engl. J. Med. 330, 15–18 (1994)

    Article  PubMed  CAS  Google Scholar 

  3. B.M. Brenner, Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 23, 647–655 (1983)

    Article  PubMed  CAS  Google Scholar 

  4. W.J. Fu, S.L. Xiong, Y.G. Fang et al., Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 41, 82–88 (2012)

    Article  PubMed  CAS  Google Scholar 

  5. M. von Eynatten, M. Baumann, U. Heemann et al., Urinary L-FABP and anaemia: distinct roles of urinary markers in type diabetes. Eur. J. Clin. Investig. 40, 95–102 (2010)

    Article  Google Scholar 

  6. T. Matsubara, H. Abe, H. Arai et al., Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab. Investig. 86(4), 357–368 (2006)

    Article  PubMed  CAS  Google Scholar 

  7. P.A. Hoodless, T. Haerry, S. Abdollah et al., MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489–500 (1996)

    Article  PubMed  CAS  Google Scholar 

  8. M. Wang, H. Jin, D. Tang et al., Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthritis Cartil. 19(6), 751–762 (2011)

    Article  CAS  Google Scholar 

  9. K.D. Tremblay, N.R. Dunn, E. Robertson, Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 28, 3609–3621 (2001)

    Google Scholar 

  10. Rosolowsky ET, Niewczas MA, Ficociello LH, et al., Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes. Res. Clin. Pract. 13(S1), S46–53 (2008)

    Google Scholar 

  11. B.M. Brenner, T.W. Meyer, T.H. Hostetter, Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N. Engl. J. Med. 307, 652–659 (1982)

    Article  PubMed  CAS  Google Scholar 

  12. M.P. O’Donnell, B.L. Kasiske, W.F. Keane, Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J. 2(8), 2339–2344 (1988)

    PubMed  Google Scholar 

  13. G. Gruden, S. Thomas, D. Burt et al., Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction Proc. Natl. Acad. Sci. USA 94, 12112–12116 (1997)

    Article  CAS  Google Scholar 

  14. W.J. Fu, B.L. Li, S.B. Wang et al., Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res. Clin. Pract. 95(1), 105–109 (2012)

    Article  PubMed  CAS  Google Scholar 

  15. R.J. Macisaac, C. Tsalamandris, M.C. Thomas et al., Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 49, 1686–1689 (2006)

    Article  PubMed  CAS  Google Scholar 

  16. L.H. Ficociello, B.A. Perkins, B. Roshan et al., Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 32, 889–893 (2009)

    Article  PubMed  CAS  Google Scholar 

  17. R. Bruce, M. Rutland, T. Cundy, Glomerular hyperfiltration in young Polynesians with type 2 diabetes. Diab. Res. Clin. Pract. 25, 155–160 (1994)

    Article  CAS  Google Scholar 

  18. P. Vedel, J. Obel, F.S. Nielsen et al., Glomerular hyperfiltration in microalbuminuric NIDD patients. Diabetologia 39, 1584–1589 (1996)

    Article  PubMed  CAS  Google Scholar 

  19. C.K. Keller, K.H. Bergis, D. Fliser, E. Ritz, Renal findings in patients with short-term type 2 diabetes. J. Am. Soc. Nephrol. 7, 2627–2635 (1996)

    PubMed  CAS  Google Scholar 

  20. S.P. Silviero, R. Friedman, M.J. Azevedo et al., Five year prospective study of the glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 19, 171–174 (1996)

    Article  Google Scholar 

  21. G.D. Tan, A.V. Lewis, T.J. James et al., Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25, 2004–2009 (2002)

    Article  PubMed  CAS  Google Scholar 

  22. Y. Jin, T. Moriya, K. Tanaka et al., Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res. Clin. Pract. 71, 264–271 (2006)

    Article  PubMed  CAS  Google Scholar 

  23. A. Mima, H. Arai, T. Matsubara et al., Urinary Smad1 is a novel marker to predict later on set of mesangial matrix expansion in diabetic nephropathy. Diabetes 57(6), 1712–1722 (2008)

    Article  PubMed  CAS  Google Scholar 

  24. G. Gruden, S. Zonca, A. Hayward et al., Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 49(4), 655–661 (2000)

    Article  PubMed  CAS  Google Scholar 

  25. S.W. Hong, M. Isono, S. Chen et al., Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am. J. Pathol. 158(5), 1653–1663 (2001)

    Article  PubMed  CAS  Google Scholar 

  26. H. Jia, L. Yu, B. Gao, Q. Ji, Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis. Endocrine 40(3), 372–378 (2011)

    Article  PubMed  CAS  Google Scholar 

  27. H. Abe, T. Matsubara, H. Arai et al., Role of Smad1 in diabetic nephropathy: molecular mechanisms and implications as a diagnostic marker. Histol. Histopathol. 26(4), 531–541 (2011)

    PubMed  CAS  Google Scholar 

  28. C.E. Hills, N. Al-Rasheed, N. Al-Rasheed et al., C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 296(3), F614–F621 (2009)

    Article  PubMed  CAS  Google Scholar 

  29. C.E. Hills, N.J. Brunskill, P.E. Squires, C-peptide as a therapeutic tool in diabetic nephropathy. Am. J. Nephrol. 31(5), 389–397 (2010)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the funds from the Scientific and Technological Projects of Dongguan City, Guangdong Province, People’s Republic of China.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xian-Zhang Huang or Qian Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fu, WJ., Fang, YG., Deng, RT. et al. Correlation of high urinary Smad1 level with glomerular hyperfiltration in type 2 diabetes mellitus. Endocrine 43, 346–350 (2013). https://doi.org/10.1007/s12020-012-9741-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9741-9

Keywords

Navigation